Choice Hotels (CHH) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.56 per share. This compares to earnings of $1.55 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.38%. A quarter ago, it was expected that this hotel franchiser would post earnings of $2.18 per share when it actually produced earnings of $2.1, delivering a surprise of -3.67%.Over the last four quarters, the comp ...

Core Insights - GoDaddy (GDDY) is set to report its fourth-quarter 2025 results on February 24, with expected revenues between $1.26 billion and $1.28 billion, indicating a 6% growth at the mid-point compared to the previous year [2][10] - The Zacks Consensus Estimate for fourth-quarter revenues is $1.27 billion, suggesting a 6.39% year-over-year increase, while the consensus for earnings is $1.58 per share, reflecting an 11.27% growth from the prior year's figure [3] Revenue Expectations - GoDaddy anticipates Applications & Commerce (A&C) revenue growth in the low to mid-teens, with A&C revenues estimated at $499.1 million, indicating a 13.1% year-over-year rise [5] - Core platform revenues are expected to reach $769.5 million, suggesting a 2.4% year-over-year growth [5] Business Drivers - The company is expected to benefit from strong adoption of high-margin subscriptions, including GoDaddy Capital, Rate Saver, and Faster Payouts, which are designed to help entrepreneurs streamline operations and reduce costs [6] - GoDaddy Airo and Ask Airo tools are driving better attachment rates, higher average order sizes, and improved retention, with bookings estimated at $1.31 billion, suggesting a 6.8% year-over-year growth [7][10] Challenges - Despite positive growth indicators, GoDaddy faces challenges such as macroeconomic conditions, foreign exchange impacts, contract expirations, and customer renewal headwinds [7][10] Earnings Outlook - According to the Zacks model, GoDaddy currently has an Earnings ESP of 0.00% and a Zacks Rank of 2, indicating a moderate outlook for an earnings beat [8]

Key Takeaways IBRX soars 41.9% after the EC cleared Anktiva plus BCG for BCG-unresponsive NMIBC CIS in the EU.The IBRX combo therapy showed a 71% complete response rate in the phase II/III QUILT-3.032 study.IBRX to submit more data to confirm Anktiva's efficacy and safety, with EU approval subject to annual renewal.Shares of ImmunityBio, Inc. (IBRX) soared 41.9% on Wednesday after the company announced that the European Commission (EC) has granted conditional marketing authorization for Anktiva (nogapendeki ...

Key Takeaways EverQuote expects Q4 revenues of $174M-$180M, implying 20% YoY growth at midpoint. Automotive and Home and Renters gained from higher carrier spend for referrals. Variable marketing margin may dip due to pricing pressure; buybacks likely aided the bottom line. EverQuote, Inc. (EVER) is expected to register an improvement in its top and bottom lines when it reports fourth-quarter 2025 results on Feb. 23, after the closing bell.The Zacks Consensus Estimate for EVER’s fourth-quarter revenues is p ...

CenterPoint Energy (CNP) came out with quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.4 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -1.10%. A quarter ago, it was expected that this energy delivery company would post earnings of $0.46 per share when it actually produced earnings of $0.5, delivering a surprise of +8.7%.Over the last four quarter ...

Core Viewpoint - Cenovus Energy reported quarterly earnings of $0.36 per share, exceeding the Zacks Consensus Estimate of $0.28 per share, and showing significant growth from $0.05 per share a year ago, indicating a strong earnings surprise of +30.91% [1] Financial Performance - The company achieved revenues of $7.81 billion for the quarter ended December 2025, which fell short of the Zacks Consensus Estimate by 19.2% and decreased from $8.4 billion year-over-year [2] - Over the last four quarters, Cenovus has surpassed consensus EPS estimates four times but has only topped consensus revenue estimates once [2] Stock Performance - Cenovus shares have increased approximately 31.5% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.5% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $0.22 for the coming quarter and $1.20 for the current fiscal year, alongside projected revenues of $9.69 billion and $36.36 billion respectively [7] - The Zacks Rank for Cenovus is currently 5 (Strong Sell), indicating expectations of underperformance in the near future due to unfavorable estimate revisions prior to the earnings release [6] Industry Context - The Oil and Gas - Integrated - Canadian industry, to which Cenovus belongs, is currently ranked in the bottom 15% of over 250 Zacks industries, suggesting a challenging environment for stock performance [8]

Core Insights - Deere (DE) reported quarterly earnings of $2.42 per share, exceeding the Zacks Consensus Estimate of $1.92 per share, but down from $3.19 per share a year ago, resulting in an earnings surprise of +26.21% [1] - The company achieved revenues of $8 billion for the quarter, surpassing the Zacks Consensus Estimate by 5.22%, compared to $6.81 billion in the same quarter last year [2] - Deere's stock has increased by approximately 27.4% since the beginning of the year, significantly outperforming the S&P 500's gain of 0.5% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $5.55, with projected revenues of $11.32 billion, and for the current fiscal year, the EPS estimate is $16.82 on revenues of $40 billion [7] - The trend of estimate revisions for Deere was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Manufacturing - Farm Equipment industry, to which Deere belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% of industries [8] - Alamo Group (ALG), another company in the same industry, is expected to report quarterly earnings of $2.06 per share, reflecting a year-over-year decline of -13.8%, with revenues projected at $399.6 million, up 3.7% from the previous year [9][10]

Core Viewpoint - Epam (EPAM) reported quarterly earnings of $3.26 per share, exceeding the Zacks Consensus Estimate of $3.16 per share, and showing an increase from $2.84 per share a year ago, indicating a positive earnings surprise of +3.17% [1] Financial Performance - The company achieved revenues of $1.41 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.08%, and up from $1.25 billion in the same quarter last year [2] - Over the last four quarters, Epam has consistently exceeded consensus EPS estimates and revenue estimates [2] Stock Performance - Epam shares have declined approximately 18.2% since the beginning of the year, contrasting with the S&P 500's gain of 0.5% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.80 on revenues of $1.4 billion, while for the current fiscal year, the estimate is $12.56 on revenues of $5.81 billion [7] - The trend of earnings estimate revisions for Epam was mixed prior to the earnings release, which may change following the latest results [6] Industry Context - The Computers - IT Services industry, to which Epam belongs, is currently ranked in the top 36% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Core Insights - Nutrien Ltd. reported a significant profit increase to $580 million or $1.18 per share for Q4 2025, up from $118 million or 23 cents in the same quarter last year [1] - Adjusted earnings per share, excluding one-time items, were 83 cents, an increase from 31 cents year-over-year, although it fell short of the Zacks Consensus Estimate of 87 cents [1] - Sales rose approximately 5% year-over-year to $5,340 million, surpassing the Zacks Consensus Estimate of $5,207.3 million [1] Segment Performance - The Nutrien Ag Solutions (Retail) segment experienced a 1% decline in sales year-over-year, totaling $3,144 million, attributed to lower sales volumes and reduced demand for phosphate, yet it exceeded the estimate of $2,883.3 million [2] - The Potash division saw a 37% year-over-year increase in sales, reaching $736 million, although it missed the estimate of $857.9 million due to lower sales volumes [3] - The Nitrogen segment reported sales of $1,093 million, an 11% increase year-over-year, beating the estimate of $657.6 million, despite a decline in sales volumes due to facility shutdowns [4] - The Phosphate segment generated sales of $483 million, up around 17% year-over-year, exceeding the estimate of $288.1 million [4] Financial Overview - At the end of the quarter, Nutrien had cash and cash equivalents of $701 million, down approximately 18% year-over-year, while long-term debt increased by 5.3% to $9,350 million [5] - Cash provided from operating activities was reported at $2,977 million for the quarter [5] Future Outlook - The company projects retail adjusted EBITDA for 2026 to be between $1.75 billion and $1.95 billion, indicating high-single digit growth in proprietary products gross margins and mid-single digit increases in North American crop nutrient sales volumes [6] - Expected potash sales volumes are projected to be between 14.1 million and 14.8 million tons, while nitrogen sales volumes are forecasted at 9.2 million to 9.7 million tons [7] - Capital expenditures are anticipated to be between $2 billion and $2.1 billion, including $400 million for growth investments [8]

Pediatrix Medical Group (MD) came out with quarterly earnings of $0.5 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.51 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4.94%. A quarter ago, it was expected that this physician group would post earnings of $0.46 per share when it actually produced earnings of $0.67, delivering a surprise of +45.65%.Over the last four quarters ...